LA ROCHE POSAY TOLERIANE ROSALIAC AR Intensive Care

TOLERIANE Rosaliac AR Intense is a hydrating treatment for skin prone to rosacea. It corrects redness.

CONFIRMED BENEFITS

• REDUCES REDNESS: 2% Sphingobioma helps to reduce redness and supports the function of the skin's microbiome.
• SOOTHING:

  Neurosensine reduces skin sensitivity and has a soothing effect.

• PREVENTATIVE: Protects against the recurrence of redness. Relapse prevention effect.

APPLICATION

• AMOUNT: A hazelnut-sized portion
• WHEN:

  Morning and/or evening

• WHERE:

  On the face, neck, and décolletage

• APPLICATION TIP:

  Apply to cleansed face.

KEY INGREDIENTS AT A GLANCE

• SPHINGOBIOMA: Sphingobioma, a bacterial extract from La Roche-Posay thermal water, supports microbiome function.
• NEUROSENSINE: An active ingredient that is intensely soothing for the skin. Neurosensine is also an endogenous molecule that acts against skin sensitivity and specifically relieves skin irritations.
• THERMAL WATER: The mineral components of thermal water promote skin regeneration and have anti-inflammatory properties. At the same time, the soothing water ensures a pleasant skin sensation.

AQUA / WATER / EAU • GLYCERIN • ISOSTEARYL NEOPENTANOATE • BUTYLENE GLYCOL • BORON NITRIDE • BUTYROSPERMUM PARKII BUTTER / SHEA BUTTER • CI 77891 / TITANIUM DIOXIDE • PENTYLENE GLYCOL • HYDROGENATED COCO-GLYCERIDES • POLYSORBATE 20 • ZEA MAYS STARCH / CORN STARCH • SCHISANDRA SPHENANTHERA FRUIT EXTRACT • TIN OXIDE • SORBITAN OLEATE • GLYCERYL ACRYLATE/ACRYLIC ACID COPOLYMER • GLYCERYL STEARATE CITRATE • ISOHEXADECANE • SPHINGOMONAS FERMENT EXTRACT • SILICA • ALUMINUM HYDROXIDE • MANNITOL • AMMONIUM POLYACRYLOYLDIMETHYL TAURATE • HYDROGENATED LECITHIN • CAPRYLYL GLYCOL • CITRIC ACID • TRISODIUM ETHYLENEDIAMINE DISUCCINATE • ACETYL DIPEPTIDE-1 CETYL ESTER • MALTODEXTRIN • POLYSORBATE 80 • ACRYLAMIDE/SODIUM ACRYLOYLDIMETHYLTAURATE COPOLYMER • MICA • CI 77288 / CHROMIUM OXIDE GREENS • CI 77491 / IRON OXIDES • CI 77492 / IRON OXIDES • CI 77499 / IRON OXIDES

Should the product come into contact with the eyes, rinse them thoroughly immediately.

WHAT YOU CAN EXPECT

• AFTER 4 WEEKS -72% BURNING* *Clinical study with 41 subjects aged 23-65, 100% with sensitive skin and permanent facial redness. Clinical evaluation at D0, D28 and D35. (1 week after discontinuation).
• AFTER 4 WEEKS -54% FREQUENCY OF FLARE-UPS* *Clinical study with 41 subjects aged 23-65, 100% with sensitive skin and permanent facial redness. Clinical evaluation at D0, D28 and D35. (1 week after discontinuation).
• IN 35 DAYS -68% SKIN DRYNESS *Clinical study with 41 subjects aged 23-65, 100% with sensitive skin and permanent facial redness. Clinical evaluation at D0, D28 and D35. (1 week after discontinuation).